Barbituric Acid

Barbituric Acid

SCHEMBL45717

O=C1CC(=O)NC(O)=N1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Barbituric Acid SCHEMBL20522064 0.98 SRC (0.32)
Barbituric Acid SCHEMBL8495242 0.89
Barbituric Acid SCHEMBL691401 0.89 SRC (0.33)
Barbituric Acid SCHEMBL8492901 0.88 SRC (0.32)
Barbituric Acid SCHEMBL9571696 0.83 MEN1 (0.34)
Barbituric Acid SCHEMBL7529989 0.83 ITGB3 (0.32)
Allobarbital SCHEMBL20241601 0.76 MMP9 (0.33)
Barbituric Acid SCHEMBL2453572 0.74 KLKB1 (0.30)
SCHEMBL1319284 0.70
Thiobarbituric SCHEMBL22275895 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 18574 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024151969-A1 POTASSIUM CHANNEL BLOCKERS OR DERIVATIVES THEREOF FOR PREVENTING, ALLEVIATING, AND/OR TREATING MORBIDITY AND MORTALITY INDUCED BY PATHOGENS OR OTHER INDUCERS OF IMMUNE EXHAUSTION AND/OR EXCESS IMMUNE ACTIVATION UNIVERSITY OF ROCHESTER (US) 2024-07-18 WO claimed
US-20240238250-A1 METHOD OF USING PIROMELATINE FOR TREATING PARASOMNIAS ASSOCIATED WITH LOSS OF REM SLEEP ATONIA NEURIM PHARMACEUTICALS (1991) LTD. (IL) 2024-07-18 US claimed
WO-2024150170-A1 PIROMELATINE FOR TREATING PARASOMNIAS ASSOCIATED WITH LOSS OF REM SLEEP ATONIA NEURIM PHARMACEUTICALS (1991) LTD. (IL) 2024-07-18 WO claimed
US-20240226058-A1 STABILIZED CANNABINOID COMPOSITIONS AND METHODS OF PREPARATION THEREOF Cannacraft, Inc. (US) 2024-07-11 US claimed
WO-2024130044-A1 TREATMENT OF PSYCHOLOGICAL FACTORS AFFECTING OTHER MEDICAL CONDITIONS (PFAOMC) LUMINOUS MIND INC. (US) 2024-06-20 WO claimed
CN-118206589-A Chiral separation porous material and preparation method thereof 吉林大学 2024-06-18 CN claimed
US-20240189295-A1 NONSELECTIVE METABOTROPIC GLUTAMATE RECEPTOR ACTIVATORS FOR TREATMENT OF ANOREXIA NERVOSA AND BINGE EATING DISORDER THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) 2024-06-13 US claimed
CN-118121577-A Method for treating substance abuse 感知神经科学公司 2024-06-04 CN claimed
US-11993670-B2 Zwitterionic biocompatible polymers, methods, and uses thereof THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2024-05-28 US claimed
WO-2024100531-A1 METHOD OF TREATING SEIZURE DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2024-05-16 WO claimed
WO-1982003986-A1 MEDICINAL COMPOSITION JENKINSON ALFRED 1982-11-25 WO claimed
US-4296202-A BUFFER, AZO DYE ESTER BOEHRINGER MANNHEIM GMBH (DE) 1981-10-20 US claimed
US-4294916-A METHINE DYES CIBA-GEIGY AG (CH) 1981-10-13 US claimed
US-4244939-A RADIOIMMUNOASSAY BAXTER TRAVENOL LABORATORIES, INC. (US) 1981-01-13 US claimed
US-4205952-A METALLO-HAPTEN, METALLO-BINDER LABELLED COMPONENT TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) 1980-06-03 US claimed
US-4126684-A 4-AMINO-3-P-HALOPHENYLBUTYRIC ACIDS AND THEIR DERIVATIVES USED IN THE CONTROL OF NARCOTIC ABUSE CIBA-GEIGY CORPORATION (US) 1978-11-21 US claimed
US-4098789-A ANTIINFLAMMATORY AGENTS E. R. SQUIBB & SONS, INC. (US) 1978-07-04 US claimed
US-4064125-A Substituted amides having antiinflammatory activity E. R. SQUIBB AND SONS, INC. (US) 1977-12-20 US claimed
US-4064042-A SULFONATE STYRENE-DIVINYLBENZENE COPOLYMER ROHM AND HAAS COMPANY (US) 1977-12-20 US claimed
US-4036823-A Barbituric acid antigenic conjugates, their preparation, antibodies and use BIOLOGICAL DEVELOPMENTS, INC. (US) 1977-07-19 US claimed